02137cam a22004574a 450000100090000000300040000900500170001300800410003001000170007101500190008801600200010701600180012702000400014502000180018503500230020304000450022604200080027105000220027906000150030106000250031608200230034124501090036426000410047330000630051450400510057750506280062865000250125665000300128165000250131165000240133665000250136065000240138565000240140965000330143365000210146665000300148770000240151770000210154170000260156285600910158814294124OSt20191003170053.0060309s2006    nyuaf    b    001 0 eng    a  2006040302  2bnbaGBA6464857 a1012716352DNLM7 a0134646612Uk  a0824728971 (Hardcover : alk. paper)  a9780824728977  a(OCoLC)ocm65195279  aDNLM/DLCcDLCdNLMdBAKERdUKMdC#PdDLC  apcc00aRC521b.D459 200600a2006 J-22410aWM 220bD376393 200600a616.830 75 HER22304aThe dementias :bearly diagnosis and evaluation /cedited by Karl Herholz, Daniela Perani, Chris Morris.  aNew York :bTaylor & Francis,c2006.  axv, 455 p., [8] p. of plates :bill. (some col.) ;c24 cm.  aIncludes bibliographical references and index.  aThe Clinical Issues. Neuropsychological Screening and Advanced Neuropsychological Tests.
Biomarkers in Blood and Cerebrospinal Fluid. Genetics: Facts and Perspectives. Approaches to the Identification of Novel Diagnostic and Therapeutic Targets in Dementia. Quantitative and Functional MRI Techniques. Perfusion SPECT. FDG PET: Imaging Cerebral Glucose Metabolism with Positron Emission Tomography. Imaging of Neurotransmitter Systems in Dementia. Development and Application of beta-Amyloid Imaging Agents in Alzheimer's Disease. A View on Early Diagnosis of Dementias from Neuropathology. Guideline and Perspective. Index 0aDementiaxDiagnosis. 0aNeuropsychological tests. 0aBiochemical markers. 0aDiagnostic imaging.12aDementiaxdiagnosis.12aDementiaxetiology.22aBiological Markers.22aDiagnostic Imagingxmethods.22aEarly Diagnosis.22aNeuropsychological Tests.1 aHerholz, K.q(Karl)1 aPerani, Daniela.1 aMorris, Chris,d1965-423Publisher descriptionuhttp://www.loc.gov/catdir/enhancements/fy0648/2006040302-d.html